Glycolithocholic acid 3-sulfate (SLCG) is a cholic acid derivative and a metabolite of glycolithocholic acid. Glycolithocholic acid 3-sulfate inhibits replication of HIV-1 in vitro. Glycolithocholic acid 3-sulfate can be used for the research of HIV infection and gallbladder disease In Vitro Glycolithocholic acid 3-sulfate (100 μg/mL) protects MT-4 cells against HIV-1-induced cytopathogenicity. Glycolithocholic acid 3-sulfate (200 μg/mL) shows no toxicity for host cells. Glycolithocholic acid 3-sulfate inhibits HIV-1 antigen expression in HIV-1-infected CEM cells. MCE has not independently confirmed the accuracy of these methods. They are for reference only. In Vivo Glycolithocholic acid 3-sulfate (24 μmoL /100 g; i.v., once) induces intrahepatic cholestasis and increases biliary cholesterol secretion in male Wistar rats with bile fistula. MCE has not independently confirmed the accuracy of these methods. They are for reference only. Animal Model: Male Wistar rats with bile fistulaDosage: 24 μmoL/100 g Administration: Intravenous injection; 24 μmoL/100 g Result: Induced intrahepatic cholestasis and increased biliary cholesterol secretion. Form:Solid IC50& Target:Microbial Metabolite